All treatments are provided under the supervision of board-certified practitioners with deep expertise in longevity medicine, peptide therapy, and neurological wellness
Persistent numbness or tingling possible nerve involvement
Semaglutide should reduce appetite, not eliminate eating
Visceral fat is stored in the abdominal cavity, wrapped around internal organs
"Our rigorous, customer-first approach strips away the friction of traditional healthcare, putting the power of health ownership back where it belongs: with the consumer. Wegovy is the only FDA-approved GLP-1 obesity pill Novo is the only company to gain FDA approval for a GLP-1 weight loss pill
The SURMOUNT-1 trial, also published in the New England Journal of Medicine, found that participants lost an average of 16.0% of body weight at the 5mg dose, 21.4% at 10mg, and 22.5% at the highest 15mg dose over 72 weeks, compared to 2.4% in the placebo group with 89% to 96% of participants (depending on dose) reaching at least 5% weight loss